Hypersensitivity following Retreatment with Carboplatin a Decade after Completion of Primary Platinum-Based Chemotherapy
The relatively rapid development of a platinum-associated hypersensitivity reaction in an ovarian cancer patient receiving second-line chemotherapy more than a decade following her last course of primary platinum-based chemotherapy demonstrates that the prolonged persistence of immune cells recogniz...
Main Authors: | Laura Williams, Maurie Markman |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-02-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/203358 |
Similar Items
-
Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
by: Jian Chen, et al.
Published: (2009-09-01) -
Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies
by: Yu-Hsiao Tai, et al.
Published: (2017-11-01) -
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
by: Shoji Nagao, et al.
Published: (2020-02-01) -
Limitations to the use of carboplatin-based therapy in advanced ovarian cancer
by: Christina Fotopoulou
Published: (2014-12-01) -
Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin
by: Kenro Chikazawa, et al.
Published: (2020-07-01)